Abbott (NYSE:ABT) chairman & CEO Miles White took to the media today to speak out against a new measure that would prevent corporate inversions, like the one included in Abbott’s sales of its generics business to Mylan Inc. (NSDQ:MYL) and in Medtronic’s (NYSE:MDT) acquisition of Covidien (NYSE:COV).
Hey, check out all the engineering jobs. Post your resume today!
